Amphastar Pharmaceuticals, Inc. , a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
Amphastar Pharmaceuticals stock last closed at $56.77, down 0.56% from the previous day, and has increased 94.42% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 1.03 percentage points. Amphastar Pharmaceuticals stock is currently +105.84% from its 52-week low of $27.58, and -16.1% from its 52-week high of $67.66.
As of Dec 8, 2023, there are 47.91M shares of AMPH outstanding. The market capitalization of AMPH is $2.72B. In the last 24 hours, 238,592 AMPH shares were traded.
How to Buy Amphastar Pharmaceuticals Stock
Not sure how to invest in Amphastar Pharmaceuticals stock? Here's how.
Decide where to buy Amphastar Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Amphastar Pharmaceuticals stock.
Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Fund your investment account: Choose your method of payment and add your info.
Evaluate Amphastar Pharmaceuticals stock: The Amphastar Pharmaceuticals ticker symbol is AMPH. Is Amphastar Pharmaceuticals stock a good investment? Should you buy shares of AMPH? How do AMPH's underlying business fundamentals look? Do top analysts think Amphastar Pharmaceuticals is a good buy? Why has AMPH's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if AMPH is a good stock to buy).
Execute your AMPH buy order: Decide if you will purchase AMPH shares at the current market price or use a limit order to purchase AMPH shares at a specific price.
Keep an eye on your AMPH position: Create a watchlist to keep tabs on your new investment in Amphastar Pharmaceuticals shares.
Step 1: Decide where to buy Amphastar Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy AMPH shares.
A brokerage account enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world financial markets: From Technology to Energy, New York to Tokyo — you can fill your portfolio with stocks from the world's leading stock exchanges.
Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal information so you can buy AMPH stock today.
Last year, AMPH earnings were $135.29M. Over the past four year, AMPH's earnings have grown by 26.2% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 4.99%.
Last year, AMPH revenue was $601.31M. During the last 5 year, AMPH's revenue has grown by 17.77% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 31.39%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.